Today Bloomberg reported about regenerative medicine in Japan. Four years ago, Shinya Yamanaka, a Kyoto University professor, had won the Nobel Prize for his work in stem cell biology, which has since sparked investment into regenerative medicine in Japan. Companies like Fujifilm and Hitachi Ltd. have also made investments on technology and products using Yamanaka’s discovery. Through an acquisition of Japan Tissue Engineering Co. Ltd, Fujifilm is already supplying patients in Japan with artificially generated skin and cartilage. Read the full interview with FUJIFILM Corporation Mr. Toda, Executive Vice President, and Mr. Ban, General Manager of Regenerative Medicine business.
You must log in to post a comment.